Pharmacology of the immunomodulator Trekrezan
Animal research · 2009
- What was studied
- Experimental immune models, including bronchopulmonary inflammation in rats
- Main finding
- The dissertation transcription compares Trekrezan, Metaprot and Polyoxidonium, including combinations. Trekrezan plus Metaprot produced larger changes in selected energy-metabolism and immune endpoints than either alone.
Study data at a glance
- Participants or experimental model
- Experimental immune models, including bronchopulmonary inflammation in rats
- Reported results
- The dissertation transcription compares Trekrezan, Metaprot and Polyoxidonium, including combinations. Trekrezan plus Metaprot produced larger changes in selected energy-metabolism and immune endpoints than either alone.
Study limitations and source details
Study limitations
- Author’s abstract/transcription is not a completed appraisal of the original thesis.
- This is animal combination research, not a human regimen or independent replication of the same program.
Source details
Author’s-abstract transcription
Citation and available abstract or selected source passages checked; complete methods and risk-of-bias appraisal pending.
Selected experimental passages
Sources checked
Citation
A. B. Zhumasheva. Pharmacology of the immunomodulator Trekrezan Kirov Military Medical Academy; dissertation author’s abstract
Related compounds
Trekrezan
Oxyethylammonium methylphenoxyacetate, a synthetic small molecule studied in Russian stress and immune research.
Bemitil
A synthetic benzimidazole derivative also called bemethyl or Metaprot. Soviet and Russian researchers studied it as an actoprotector, a drug intended to preserve physical work capacity under stress.